Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images
NCT ID: NCT06399159
Last Updated: 2024-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2023-09-01
2024-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Central Cervical Dissection for Clinical Node Negative Papillary Thyroid Carcinoma
NCT03813173
A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma
NCT05191927
Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer
NCT07299318
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
NCT06082180
Lateral Approach for Mediastinal Lymph Node Dissection in Thyroid Cancer
NCT06793579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort with Lymph Node Metastasis
Depending on the pathological findings, it is classified as the presence of lymph node metastases.
Thyroidectomy and lymph node dissection
All surgical specimens of thyroidectomy and lymph node dissection were subjected to paraffin-embedded histopathological examination, and postoperative were categorized as with cervical lymph node metastasis and without cervical lymph node metastasis.
Cohort without Lymph Node Metastasis
Depending on the pathological findings, it is classified as the absence of lymph node metastases.
Thyroidectomy and lymph node dissection
All surgical specimens of thyroidectomy and lymph node dissection were subjected to paraffin-embedded histopathological examination, and postoperative were categorized as with cervical lymph node metastasis and without cervical lymph node metastasis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thyroidectomy and lymph node dissection
All surgical specimens of thyroidectomy and lymph node dissection were subjected to paraffin-embedded histopathological examination, and postoperative were categorized as with cervical lymph node metastasis and without cervical lymph node metastasis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completed US examination within one week before surgery
* Underwent preoperative us-guided FNAC
* Completed cytological images at 400× magnification under a microscope
Exclusion Criteria
* Patients with cervical lymph nodes shown on preoperative ultrasound
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanchong Central Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiachuan Qin,MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiachuan Qin, MD
Role: STUDY_CHAIR
Nanchong Central Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanchong central hospital
Nanchong, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Review-2023-109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.